WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'3501 Infant (under 12 months) mortality rate: 532
GDP / capita (US$): 1'7121 Child (under 5 years) mortality rate: 832

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 14'075  13'634  13'217  12'825  12'457  10'101  7'845  5'847 
Births 608  591  575  559  544  459  344  271 
Surviving infants 568  550  534  518  503  412  305  244 
Pop. less than 5 years 2'566  2'484  2'417  2'349  2'292  1'866  1'397  1'123 
Pop. less than 15 years 6'575  6'382  6'200  6'018  5'843  4'619  3'601  2'771 
Female 15-49 years 3'217  3'104  2'997  2'902  2'814  2'311  1'775  1'273 

Number of reported case

(Click for retrospective incidence data for Zambia)
Diphtheria 12 
Japanese encephalitis
Measles 896  13'234  15'754  26  140  30'930  6'748  98'659 
Mumps 13'728  6'213 
Pertussis 681  162  200  21'232 
Polio* 79  276 
Rubella 134  1'124  13  257 
Rubella (CRS)
Tetanus (neonatal) 13  130  57 
Tetanus (total) 16  193  57  409 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Zambia)
Vaccine year result method % card seen                                                
BCG 2010  98  EPI   76.9  83  88  93  99*  99*  100  97 
DTP1 2010  98  EPI   76.9  86  87  92  98  93 
DTP3 2010  93  EPI   76.9  78  81  84  98  95  76  71 
HepB_BD         
HepB3 2010  93  EPI   76.9  78  81  84  98  95 
Hib3 2010  93  EPI   76.9  78  81  84  98  95 
JapEnc         
MCV 2010  90  EPI   76.9  95  83  97  92  89  85  68 
MCV2         
PCV1         
PCV3         
Pol3 2010  90  EPI   76.9  70  83  81  96  97  79  70 
Rota1         
Rota_last         
Rubella1         
TT2plus 2001  27  DHS   79.5  71  74  72  71  75  61 
PAB         
VAD1          59  99*  90  96 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Zambia)
BCG 83  88  92  92  91  94  97 
DTP1 86  87  92  96  95  94  97 
DTP3 78  81  83  94  87  85  91 
HepB3 78  81  83  94  87 
Hib3 78  81  83  94  87 
MCV 83  83  96  90  87  85  90 
PAB 81  81  90  90  90  78  62 
PCV3
Pol3 83  83  80  93  90  85  90 
Rota_last

Number of districts in the country 72  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 38
From 80 to 89% 32
From 50 to 79% 24
Less than 50% 6
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2010 - 2014  2006-2010  2006-2011  5 yrs 
Nº of districts with microplans that include activities to raise immunization coverage number 72  72  72  72    70  72 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 72  72  72  72  72  72  72 
Nº districts with DTP3 coverage >=80% number 50  45  49  62  55  53  60 
% of districts with DTP3 coverage >=80% From 0 to 100% 69  63  68  86  76  74  83 
Nº districts with measles (MCV1) coverage >=95% number 37  25  42  32  23     
% of districts with MCV1 coverage >=95% From 0 to 100% 51  35  58  44  32     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR   Yes  Yes  Yes    Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   29  19  95  73  24  85 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.